Oldelft parent issues profit warning

Article

The parent of Dutch x-ray developer Oldelft issued a warning last month that it expects to post a net loss for 1998. Delft Instruments said that restructuring charges were the main factor in the loss. Also, orders that were expected for the end of the

The parent of Dutch x-ray developer Oldelft issued a warning last month that it expects to post a net loss for 1998. Delft Instruments said that restructuring charges were the main factor in the loss. Also, orders that were expected for the end of the year failed to materialize.

Delft expects to post an after-tax operating loss of $1.41 million for the year, compared with a profit of $7.1 million in 1997. After one-time gains and charges, Delft will post an after-tax net loss of $21.6 million. Delft recorded a one-time gain due to the sale of its Enraf-Nonius business, but that benefit was outweighed by restructuring costs.

Delft began reorganizing in October to return to profitability. The restructuring included job cuts and the sale of unprofitable businesses. Delft plans to keep its ultrasound activities as well as Oldelft, which will focus on digital products such as its Digidelca-C digital chest system. Oldelft’s R&D, sales, and marketing activities were folded into those of Nucletron, which resulted in the loss of about 40 Oldelft jobs.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.